Announced Sat, 17 May · 14:34 IST

Link Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 ,inter alia, to consider and approve Audited financial results ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Link Pharma Chem Ltd has informed BSE that its Board of Directors will meet on Tuesday, 27th May 2025 to consider, approve and take on record the audited financial results along with the audit report for the quarter and financial year ended 31st March 2025. The filing is made under Regulation 29(1) of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The trading window for designated persons is already closed since 1st April 2025 and will reopen 48 hours after the results are declared. No financial figures, segment details or commentary have been provided in this intimation.

Likely market impact

This is a routine procedural filing with no direct impact on shareholders. Investors should watch the 27th May 2025 results announcement for actual earnings, dividend declaration (if any) and management commentary.